Skip to content

Study on the Safety and efficacy of curative embolization via arterial approach in the treatment of Cerebral Arteriovenous Malformations

Study on the Safety and efficacy of curative embolization via arterial approach in the treatment of Cerebral Arteriovenous Malformations

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500105618
Enrollment
Unknown
Registered
2025-07-08
Start date
2025-07-31
Completion date
Unknown
Last updated
2025-07-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Brain Arteriovenous malformations

Interventions

Observation Group:None

Sponsors

The First Hospital of Hebei Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 80 Years

Inclusion criteria

Inclusion criteria: (1) Age <80 years old; (2) Patients with clearly diagnosed bAVM rupture and bleeding who require interventional treatment and meet the indications for interventional embolization therapy in this study; (3) The patient or the patient's legal representative agrees and requests interventional embolization treatment, as well as agrees to the information collection of this study, and has signed the informed consent form;

Exclusion criteria

Exclusion criteria: (1) Patients who have previously undergone interventional embolization, surgical operation or gamma knife treatment and cannot provide complete clinical and imaging data; (2) Bleeding is located in important functional areas, leading to unstable vital signs of the patient or an expected survival period of less than 6 months

Design outcomes

Primary

MeasureTime frame
The immediately occlusion rate of nidus after embolization;The occlusion rate of AVM nidus within 6 months to 1 year;

Secondary

MeasureTime frame
The incidence of perioperative complications;

Countries

China

Contacts

Public ContactConghui Li

The First Hospital of Hebei Medical University

13363880072@163.com+86 186 3388 9708

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026